This is huge & significant news!
What assurances have the FDA given to Mesoblast to change tact again and abandon the adult GVHD trial?
It must have been a very strong signal!
The market has not digested this 4C properly, as apart from saving $$$ on the adult trial, this pathway (label extension) is much quicker for the 5X larger adult population
GL MSB’ers - onwards & upwards
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-21
-
- There are more pages in this discussion • 184 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.020(1.83%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.406M | 3.083M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 41221 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 35022 | 24 |
View Market Depth
| Last trade - 15.38pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |